Literature DB >> 6238910

Left ventricular mass reduction during salt depletion in arterial hypertension.

L A Ferrara, G de Simone, F Pasanisi, M Mancini, M Mancini.   

Abstract

Long-term therapy with antihypertensive agents that reduce sympathetic nervous system activity has been demonstrated by echocardiographic measurements to reverse left ventricular hypertrophy. This investigation evaluated the effects of salt depletion obtained by both chlorthalidone (25 mg/day) and severe restriction of salt intake (about 1016 mg Na+/day) on left ventricular mass (LVM) in as short a time as 12 weeks. Before the study, the patients had been off medication and on a balanced diet without salt restriction for at least 2 weeks; they were then randomly allocated to either the diuretic or low-salt regimen for 6 weeks and finally to alternative treatment according to a crossover model. Blood pressure, body weight, myocardial mass, and noninvasive measurements of left ventricular function (LVF) were determined at baseline and at the end of both periods of treatment. Results were evaluated by two-way analysis of variance in randomized blocks. Systolic and diastolic blood pressure and LVM were significantly and similarly reduced by diuretic therapy or salt restriction. A significant correlation was demonstrated between noninvasive measurements of LVM, expressed as cross-sectional area, and systolic blood pressure. No impairment of LVF could be detected over the treatment period.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6238910     DOI: 10.1161/01.hyp.6.5.755

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  20 in total

Review 1.  Regression of increased left ventricular mass by antihypertensives.

Authors:  C J Lavie; H O Ventura; F H Messerli
Journal:  Drugs       Date:  1991-12       Impact factor: 9.546

2.  Comparison between the effects of urapidil and methyldopa on left ventricular hypertrophy and haemodynamics in humans.

Authors:  C A Feldstein; A O Olivieri; R P Sabarís
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 3.  Electrophysiological impact of diuretics in heart failure.

Authors:  L Storstein
Journal:  Br Heart J       Date:  1994-08

4.  Changes in left ventricular mass during a double-blind study with chlorthalidone and slow-release nifedipine.

Authors:  L A Ferrara; G de Simone; M Mancini; M L Fasano; F Pasanisi; G Vallone
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

5.  Influence of dietary sodium modulation on electrocardiographic voltage criteria for left ventricular hypertrophy in normotensive individuals.

Authors:  Carol Larson; Anand Vaidya; Bei Sun; Jonathan S Williams
Journal:  J Investig Med       Date:  2012-01       Impact factor: 2.895

Review 6.  Left ventricular hypertrophy. Prevalence in older patients and management.

Authors:  E Paciaroni; A Fraticelli
Journal:  Drugs Aging       Date:  1995-04       Impact factor: 3.923

7.  Dietary sodium alters the prevalence of electrocardiogram determined left ventricular hypertrophy in hypertension.

Authors:  Anand Vaidya; Rhonda Bentley-Lewis; Xavier Jeunemaitre; Gail K Adler; Jonathan S Williams
Journal:  Am J Hypertens       Date:  2009-03-05       Impact factor: 2.689

Review 8.  Salt intake, blood pressure, and cardiovascular structure.

Authors:  A H Beil; R E Schmieder; F H Messerli
Journal:  Cardiovasc Drugs Ther       Date:  1994-06       Impact factor: 3.727

Review 9.  Current drug treatment and treatment patterns with antihypertensive drugs.

Authors:  E D Freis; V Papademetriou
Journal:  Drugs       Date:  1996-07       Impact factor: 9.546

Review 10.  Risk and management of hypertension-related left ventricular hypertrophy.

Authors:  K K Teo
Journal:  Drugs       Date:  1995-12       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.